CDR recommendation is now available for Repatha
Files
Evolocumab
Published on: June 4, 2015
Result type: Reports
Project Number: SR0441-000
Product Line: Common Drug Review
Project Status: Active
Generic Name: Evolocumab
Brand Name: Repatha
Manufacturer: Amgen Canada Inc.
Indications: Primary hyperlipidemia and mixed dyslipidemia
Project Number: SR0441-000
Submission Type: New
Project Status: Active
Call For Patient Input: June 4, 2015
Patient Input Closed: July 24, 2015
Date Submission Received: June 30, 2015
Date Recommendation Issued: February 19, 2016
Recommendation Type: List with clinical criteria and/or conditions